Theravance Biopharma Inc
Filings
Newest firstThe annual , the quarterly and the filed between them when something material happens.
- Sep 238-KMaterial agreement and acquisition or sale of assets completed1.012.013.013.035.015.025.038.019.01
- Sep 188-KShareholder vote5.07
- Sep 108-KOther events8.01
- Aug 258-KOther events8.019.01
- Aug 1110-QQuarterly report
- Aug 108-KResults of operations2.029.01
- Jun 298-KMaterial agreement and Regulation FD disclosure1.017.018.019.01
- Jun 238-KOfficer or director change5.02
- Jun 128-KShareholder vote5.07
- May 710-QQuarterly report
- May 78-KResults of operations2.029.01
- Mar 308-KOther events8.01
- Mar 2310-KAnnual report
- Mar 198-KResults of operations2.029.01
- Mar 38-KResults of operations and Regulation FD disclosure2.022.057.019.01
- Jan 128-KRegulation FD disclosure7.019.01
- Dec 8, 20258-KOther events8.019.01
- Nov 12, 202510-QQuarterly report
- Nov 10, 20258-KResults of operations2.029.01
- Aug 25, 20258-KOther events8.019.01
- Aug 20, 20258-KOther events8.01
- Aug 13, 202510-QQuarterly report
- Aug 12, 20258-KResults of operations2.029.01
- Jun 26, 20258-KOther events8.019.01
- Jun 6, 20258-KOther events8.01
- Jun 2, 20258-KMaterial agreement and acquisition or sale of assets completed1.012.017.019.01
- May 20, 20258-KShareholder vote5.07
- May 12, 202510-QQuarterly report
- May 8, 20258-KResults of operations2.029.01
- Mar 7, 202510-KAnnual report
- Feb 26, 20258-KResults of operations2.029.01
- Nov 14, 202410-QQuarterly report
- Nov 12, 20248-KResults of operations2.029.01